CONCLUSION: In patients whose CA-125 level decreases to normal after chemotherapy, a doubling from the upper limit of normal has been shown to predict progression. In those with persistently elevated ...

Feasibility of bevacizumab (BEV) plus chemotherapy in heavily pretreated ovarian cancer (OC) patients (pts): A retrospective study. Background: Rising serum cancer antigen 125 (CA-125) trends within ...

Only three of eight patients (38%) with cirrhosis but without ascites (group Ia) showed elevated serum values of CA 125. However, 21 of 22 patients (95%) with cirrhotic ascites (groups Ib and Ic) had ...

The likelihood of having an elevated CA-125 level at ovarian cancer diagnosis was lower for American Indian, Asian, or Black patients versus White patients. HealthDay News — Black and American Indian ...

Maurie Markman, MD: The provocative findings of a randomized trial suggest that monitoring CA-125 levels does not confer a survival benefit. Dr. Gordon Rustin was the lead author on that study. Gordon ...

A recent retrospective analysis by Low and colleagues compared the use of laparotomy, MRI, and serum cancer antigen-125 (CA-125) levels for the detection of residual tumor in women treated for ovarian ...

A way of screening for ovarian cancer appears to detect the disease in early stages, and if confirmed in clinical trials, the test could become a routine screening for women. In the study, researchers ...

DEAR DR. ROACH: I have a history of cancer with an elevated CA-125 level. Recently I had a shingles shot and soon thereafter, my CA-125 level was high. An extensive workup showed up nothing ...

In 2022, more than 13,000 people died from ovarian cancer, according to the CDC. A common blood test for ovarian cancer is more likely to fall short for Black and Native American women, according to a ...

CA-125 is a “useful test” for ovarian cancer in primary care, especially in symptomatic women aged older than 50 years, according to a presenter at the recent National Cancer Research Institute Cancer ...

A common blood test may miss ovarian cancer in some Black and Native American patients, delaying their treatment, a new study finds. It’s the latest example of medical tests that contribute to health ...